Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Capital Science & Technology Development Group (BSTDG) is a state-owned enterprise established by the Beijing Municipal Government to accelerate the commercialization of scientific and technological achievements. The group operates as a comprehensive innovation platform, focusing on strategic sectors such as biomedicine, healthcare, and advanced manufacturing. BSTDG provides critical support to the life sciences industry through venture capital investment, the management of specialized science parks, and technology transfer services. By fostering collaborations between academic institutions and industrial partners, the group plays a pivotal role in Beijing's evolution into a global science and technology innovation hub. Its portfolio includes numerous high-growth startups in the biotechnology and medical device sectors, making it a key player in the regional healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Capital Science & Technology Group.